alere inc (ALR:New York)
Transactions by ALERE INC (ALR) in the last 6 months
Exponent Private Equity LLP entered into an agreement to acquire BBI Group from Alere Inc. (NYSE:ALR) for approximately $160 million on July 2, 2015. The final purchase price is subject to a working capital adjustment and includes a $47 million contingent consideration. In a concurrently announced transaction, Alere acquired US Diagnostics. Crescent European Specialty Lending strategy co-led the financing for the acquisition. EQT Credit and Babson Capital also provided ...
Alere Inc. (NYSE:ALR) acquired substantially all assets of USDiagnostics, Inc. for $60 million in cash on July 10, 2015. In a concurrently announced transaction, Alere will sell BBI Group to Exponent Private Equity, LLP. Alere expects the two transactions combined to be dilutive to earnings per share by approximately $0.00-$0.05 in 2015. Duane P. Donner II and Joe H. Brady III of Founders Investment Banking, LLC acted as financial advisor for USDiagnostics, Inc.
Persivia acquired Alere Analytics, Inc. from Alere Inc. (NYSE:ALR) on May 22, 2015.
SHL Telemedicine Ltd. (SWX:SHLTN) agreed to acquire Gesellschaft für Patientenhilfe DGP mbH from Alere Inc. (NYSE:ALR) for €7.6 million in cash on March 23, 2015. SHL expects to finance the transaction through a combination of existing cash and new debt. Gesellschaft für Patientenhilfe made €9.2 million in total revenues in 2014 for a net profit of €0.8 million. The transaction is expected to close within a short time-frame. The acquisition is expected to be accretive ...
|Bio-Rad Laboratories Inc||$136.43 USD||-1.18|
|PerkinElmer Inc||$47.35 USD||-0.60|
|STERIS Corp||$63.50 USD||-0.73|
|Teleflex Inc||$128.92 USD||-0.25|
|View Industry Companies|